YUJI AOKI. Comparison of Diuretic Effects between Empagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor With Osmotic Diuresis, and Tolvaptan, a Water Diuretic, in Two Type 2 Diabetic Patients Taking Sodium Diuretics. Diabetes Research, [S. l.], v. 2, n. 2, p. 45–49, 2016. DOI: 10.17140/DROJ-2-128. Disponível em: http://openventio.us/index.php/DR/article/view/1621. Acesso em: 13 oct. 2026.